All filters
E-Posters
Reconstitution Immunologique Chez Les Patients Adultes VIH Positifs en Première Ligne du Traitement Antirétroviral à Hôpital de District de Nylon, Douala, Cameroun
M. Takemegni Wandji
Presented at:
INTEREST 2020
E-Posters
Does Dolutegravir Causes Weight Gain: A Retrospective Observational Cohort Study From Lusaka, Zambia
D. Mwamba
Presented at:
INTEREST 2020
E-Posters
Effectiveness of Male Strategy (MS) in HIV Case Identification and Linkage of MLHIV to Treatment in Cameroon
E. Ngonwei Njemkerk
Presented at:
INTEREST 2020
E-Posters
DTG+3TC vs DTG+TDF/FTC (GEMINI-1&-2): Confirmed Virologic Withdrawals Through Week 96
J. Van Wyk
Presented at:
INTEREST 2020
E-Posters
Switching to DTG/3TC Fixed-Dose Combination (FDC) Is Non-inferior to Continuing a TAF-Based Regimen Through 48 Weeks: Subgroup Analyses From the TANGO Study
J. Van Wyk
Presented at:
INTEREST 2020
E-Posters
Impact of Community Resource Persons and Mobile Phone Technology on Return to HIV Care Among Loss to Follow up HIV Clients in 104 HIV Facilities in Uganda
A. Mugisa
Presented at:
INTEREST 2020
E-Posters
Optimizing HIV Treatment Among Children in Mozambique
M. Tomo De Deus
Presented at:
INTEREST 2020
E-Posters
Gender Based Violence Among Discordant Couples in Care and Associated Factors in Accessing GBV Post Care; A Cross Sectional Survey at AIDS Information Center (AIC) Uganda
E. Nagawa
Presented at:
INTEREST 2020
E-Posters
Evaluation of Second Line Antiretroviral Programmatic and Treatment Outcomes in Mozambique Between 2015-2017
A. Muteerwa
Presented at:
INTEREST 2020
E-Posters
U=U - Catalyst or Barrier for Men's Engagement in ART? Stakeholder Views From Blantyre, Malawi
A. Berner-Rodoreda
Presented at:
INTEREST 2020
E-Posters
Minimal Cross-Resistance to Tenofovir in Children and Adolescents Failing Abacavir-Based ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment.
K. Steegen
Presented at:
INTEREST 2020
E-Posters
Acceptability of Quadrimune, a New Abacavir/Lamivudine/Lopinavir/Ritonavir Paediatric Fixed Dose Combination
V. Musiime
Presented at:
INTEREST 2020
E-Posters
Prevalence of Drug Resistance Mutations Among HIV Positive Individuals With Low Level Viremia on Antiretroviral Therapy in Botswana
O. Thato Bareng
Presented at:
INTEREST 2020
E-Posters
4-in-1 Granules for HIV Treatment in Children: LOLIPOP Study Interim Analysis Results
A. Kekitiinwa
Presented at:
INTEREST 2020
E-Posters
Zimbabwe’s National Third-Line Antiretroviral Therapy Program: Cohort Description and Treatment Outcomes
C. Chimbetete
Presented at:
INTEREST 2020
E-Posters
Where Are the Men in Gaza? A Cross-Sectional Study to Understand the Residency Patterns of Male Partners of Women Accessing HIV Services in Gaza, Mozambique
S. Ndima
Presented at:
INTEREST 2020
E-Posters
Low Baseline-Resistance to Integrase Inhibitors in Cameroon: Implications in the Era of Dolutegravir-based Regimens in Sub-Saharan Africa
E. Ngoufack Jagni Semengue
Presented at:
INTEREST 2020
E-Posters
Prevalence and Factors Associated With Delayed Antiretroviral Therapy Switching at Rural Public Health Facilities in Kiboga District, Uganda
J. Nakakande
Presented at:
INTEREST 2020
E-Posters
Improving Viral Load Suppression Rates Among HIV Positive Children on ART in a Large Volume HIV Clinic in Western Uganda.
W. Akobye
Presented at:
INTEREST 2020
E-Posters
“One Size Does Not Fit All” – Views by Stakeholders, Men on ART and Men in Communities on Improving Men’s Access to and Continued Engagement in ART in Malawi
A. Berner-Rodoreda
Presented at:
INTEREST 2020
E-Posters
Early Experiences of Switching to Dolutegravir in Women Enrolled in Option B+, Malawi
E. Singogo
Presented at:
INTEREST 2020
E-Posters
Targeted CQI Improves Early Retention of HIV+ Clients Newly Initiated on Anti-Retro-Viral Therapy; Lessons From the Pediatric Infectious Diseases Clinic-Mulago, Uganda
L. Engurat
Presented at:
INTEREST 2020